AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,280,000 | -33.3% | 71,534 | -68.7% | 0.50% | -38.8% |
| Q3 2019 | $6,412,000 | -35.0% | 228,294 | -12.3% | 0.82% | +20.1% |
| Q2 2019 | $9,858,000 | +4.1% | 260,400 | +7.3% | 0.68% | +55.9% |
| Q1 2019 | $9,470,000 | +398.2% | 242,700 | +172.1% | 0.44% | +234.4% |
| Q4 2018 | $1,901,000 | +59.1% | 89,200 | +195.4% | 0.13% | +92.6% |
| Q3 2018 | $1,195,000 | -74.5% | 30,200 | -75.3% | 0.07% | -75.2% |
| Q2 2018 | $4,680,000 | -19.0% | 122,500 | -36.3% | 0.27% | -25.7% |
| Q1 2018 | $5,775,000 | +96.0% | 192,200 | +103.8% | 0.37% | +133.5% |
| Q4 2017 | $2,946,000 | +31.2% | 94,300 | +17.6% | 0.16% | +31.7% |
| Q3 2017 | $2,246,000 | +375.8% | 80,200 | +189.5% | 0.12% | +300.0% |
| Q1 2017 | $472,000 | – | 27,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |